Atlas Trials

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Clinical trial NCT01067989 · TERMINATED

Trial details

NCT number
NCT01067989
Sponsor
HaEmek Medical Center, Israel
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
ChemotherapyBreast Cancer, Metastatic
Start date
2010-03-01
Primary completion
2014-04-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.